Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification

Epigenomics

Volumn 4, Issue 5, 2012, Pages 491-501

  Cosialls, Ana M ^a   Santidrián, Antonio F ^a   Coll Mulet, Llorenç ^a,b   Iglesias Serret, Daniel ^a   González Gironès, Diana M ^a   Pérez Perarnau, Alba ^a   Rubio Patiño, Camila ^a   González Barca, Eva ^c   Alonso, Esther ^d   Pons, Gabriel ^a   Gil, Joan ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b Institut de Medicina Predictiva i Personalitzada del Cancer IMPPC   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

CLL; DNA methylation; epigenetic profiling; MS MLPA

Indexed keywords

CDH13 PROTEIN; DAPK1 PROTEIN; DNA; PROTEIN; RARB PROTEIN; TRANSCRIPTION FACTOR GATA 5; TSLC1 PROTEIN; UNCLASSIFIED DRUG; WT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DONOR; EPIGENETICS; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CADHERINS; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; GENETIC VARIATION; HUMANS; JURKAT CELLS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; REPRODUCIBILITY OF RESULTS;

EID: 84868560560     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.12.40     Document Type: Article

References (45)

1. Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer 10(1), 37-50 (2010).
2. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat. Med. 17(3), 330-339 (2011).
3. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 358(11), 1148-1159 (2008).
4. Plass C, Byrd JC, Raval A, Tanner SM, de la Chapelle A. Molecular profiling of chronic lymphocytic leukaemia: Genetics meets epigenetics to identify predisposing genes. Br. J. Haematol. 139(5), 744-752 (2007). (Pubitemid 350115737)
5. Bennett LB, Taylor KH, Arthur GL, Rahmatpanah FB, Hooshmand SI, Caldwell CW. Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia. Epigenomics 2(1), 53-70 (2010).
6. Rush LJ, Raval A, Funchain P et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 64(7), 2424-2433 (2004). (Pubitemid 38523896)
7. Kanduri M, Cahill N, Goransson H et al. Differential genome-Wide array-Based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 115(2), 296-305 (2010).
8. Tong WG, Wierda WG, Lin E et al. Genome-Wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 5(6), 499-508 (2010).
9. Yu MK, Bergonia H, Szabo A, Phillips JD. Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index. Leuk. Res. 31(6), 773-777 (2007). (Pubitemid 46855887)
10. Irving L, Mainou-Fowler T, Parker A, Ibbotson RE, Oscier DG, Strathdee G. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics 6(3), 300-306 (2011).
11. Fabris S, Bollati V, Agnelli L et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6(2), 188-194 (2011).
12. Rahmatpanah FB, Carstens S, Hooshmand SI et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 1(1), 39-61 (2009).
13. Raval A, Tanner SM, Byrd JC et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129(5), 879-890 (2007). (Pubitemid 46813150)
14. Yu L, Liu C, Vandeusen J et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37(3), 265-274 (2005). (Pubitemid 41716253)
15. Motiwala T, Majumder S, Kutay H et al. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin. Cancer Res. 13(11), 3174-3181 (2007). (Pubitemid 46944899)
16. Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 17(2), 411-415 (2003). (Pubitemid 36266919)
17. Mikeska T, Candiloro IL, Dobrovic A. The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics 2(4), 561-573 (2010).
18. Nygren AO, Ameziane N, Duarte HM et al. Methylation-specific MLPA (MS-MLPA): Simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33(14), e128 (2005).
19. Eberth S, Schneider B, Rosenwald A et al. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma. BMC Cancer 10, 517 (2010).
20. Rohrs S, Dirks WG, Meyer C et al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Mol. Cancer 8, 86 (2009).
21. Leong KJ, Wei W, Tannahill LA et al. Methylation profiling of rectal cancer identifies novel markers of early-stage disease. Br. J. Surg. 98(5), 724-734 (2011).
22. Campas C, Cosialls AM, Barragan M et al. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp. Hematol. 34(12), 1663-1669 (2006). (Pubitemid 44839000)
23. Iglesias-Serret D, Pique M, Barragan M et al. Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis 15(2), 219-229 (2010).
24. Jeuken JW, Cornelissen SJ, Vriezen M et al. MS-MLPA: An attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab. Invest. 87(10), 1055-1065 (2007). (Pubitemid 47429190)
25. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22(15), 2990-2997 (1994). (Pubitemid 24260626)
26. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res. 59(15), 3730-3740 (1999). (Pubitemid 29381880)
27. Mayor R, Casadome L, Azuara D et al. Long-Range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br. J. Cancer 100(10), 1534-1539 (2009).
28. Frommer M, McDonald LE, Millar DS et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89(5), 1827-1831 (1992).
29. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-Cell malignancies. Blood 93(12), 4347-4353 (1999). (Pubitemid 29279278)
30. Takahashi T, Shivapurkar N, Reddy J et al. DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin. Cancer Res. 10(9), 2928-2935 (2004). (Pubitemid 38619667)
31. Rossi D, Capello D, Gloghini A et al. Aberrant promoter methylation of multiple genes throughout the clinico-Pathologic spectrum of B-Cell neoplasia. Haematologica 89(2), 154-164 (2004). (Pubitemid 38796489)
32. Chim CS, Fung TK, Wong KF, Lau JS, Liang R. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-Cell chronic lymphocytic leukemia. J. Hum. Genet. 51(9), 832-838 (2006). (Pubitemid 44386830)
33. Seeliger B, Wilop S, Osieka R, Galm O, Jost E. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk. Lymphoma 50(3), 419-426 (2009).
34. Fernandez AF, Assenov Y, Martin-Subero JI et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 22(2), 407-419 (2012).
35. Martel V, Guerci A, Humbert JC et al. De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-Cell chronic lymphocytic leukaemia. Br. J. Haematol. 99(2), 320-324 (1997). (Pubitemid 27497561)
36. Chim CS, Fung TK, Wong KF, Lau JS, Law M, Liang R. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J. Clin. Pathol. 59(9), 921-926 (2006). (Pubitemid 44422844)
37. Taylor KH, Kramer RS, Davis JW et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 67(18), 8511-8518 (2007). (Pubitemid 47437425)
38. Papageorgiou SG, Lambropoulos S, Pappa V et al. Hypermethylation of the p15INK4B gene promoter in B-Chronic lymphocytic leukemia. Am. J. Hematol. 82(9), 824-825 (2007). (Pubitemid 350194514)
39. Issa JP, Zehnbauer BA, Civin CI et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res. 56(5), 973-977 (1996). (Pubitemid 26065388)
40. Toyota M, Kopecky KJ, Toyota MO, Jair KW, Willman CL, Issa JP. Methylation profiling in acute myeloid leukemia. Blood 97(9), 2823-2829 (2001).
41. Garcia-Manero G, Daniel J, Smith TL et al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin. Cancer Res. 8(7), 2217-2224 (2002). (Pubitemid 34753593)
42. Iwai M, Kiyoi H, Ozeki K et al. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia 19(8), 1367-1375 (2005). (Pubitemid 41136330)
43. Pinyol M, Cobo F, Bea S et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 91(8), 2977-2984 (1998). (Pubitemid 28227549)
44. Tsirigotis P, Pappa V, Labropoulos S et al. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur. J. Haematol. 76(3), 230-236 (2006).
45. Coll-Mulet L, Santidrian AF, Cosialls AM et al. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br. J. Haematol. 142(5), 793-801 (2008).